Amide proton transfer imaging of high intensity focused ultrasound-treated tumor tissue

Magnetic Resonance in Medicine

Volumn 72, Issue 4, 2014, Pages 1113-1122

  Hectors, Stefanie J C G ^a,b   Jacobs, Igor ^a,b   Strijkers, Gustav J ^a,b   Nicolay, Klaas ^a,b  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b Center for Imaging Research and Education (CIRE)   (Netherlands)

Author keywords

Amide proton transfer imaging; Cancer treatment response; High intensity focused ultrasound

Indexed keywords

AMIDES; BIOMARKERS; MAMMALS; PROTON TRANSFER; SIGNAL PROCESSING; ULTRASONICS;

AMIDE PROTON TRANSFERS; CONTROL GROUPS; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOGRAM ANALYSIS; SIGNAL DISTRIBUTION; SIGNAL VALUE; TREATMENT RESPONSE; TUMOR TISSUES;

TUMORS;

AMIDE; PROTON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIGH INTENSITY FOCUSED ULTRASOUND; IMAGE ANALYSIS; MOUSE; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PROTON TRANSPORT; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COLONIC NEOPLASMS; COMPUTER ASSISTED SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; RADIATION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; THERAPEUTIC USE; TREATMENT OUTCOME; TUMOR CELL LINE;

AMIDES; ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; HIGH-ENERGY SHOCK WAVES; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84921433073     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25000     Document Type: Article

References (47)

1. Hynynen K. MRI-guided focused ultrasound treatments. Ultrasonics 2010;50:221-229.
2. ter Haar G. Therapeutic applications of ultrasound. Prog Biophys Mol Biol 2007;93:111-129.
3. Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005;5:321-327.
4. Murat FJ, Poissonnier L, Pasticier G, Gelet A. High-intensity focused ultrasound (HIFU) for prostate cancer. Cancer Control 2007;14:244-249.
5. Rouviere O, Girouin N, Glas L, Ben Cheikh A, Gelet A, Mege-Lechevallier F, Rabilloud M, Chapelon JY, Lyonnet D. Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI. Eur Radiol 2010;20: 48-55.
6. Kirkham AP, Emberton M, Hoh IM, Illing RO, Freeman AA, Allen C. MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology 2008;246:833-844.
7. Schmitz AC, Gianfelice D, Daniel BL, Mali WP, van den Bosch MA. Image-guided focused ultrasound ablation of breast cancer: current status, challenges, and future directions. Eur Radiol 2008;18:1431-1441.
8. Leslie TA, Kennedy JE, Illing RO, Ter Haar GR, Wu F, Phillips RR, Friend PJ, Roberts IS, Cranston DW, Middleton MR. High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response? Br J Radiol 2008;81:564-571.
9. Leslie T, Ritchie R, Illing R, Ter Haar G, Phillips R, Middleton M, Bch B, Wu F, Cranston D. High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intraoperative estimates of treatment volume. Br J Radiol 2012;85:1363-1370.
10. Hectors SJCG, Jacobs I, Strijkers GJ, Nicolay K. Identification of high intensity focused ultrasound treated tumor tissue using a multiparametric MRI protocol and ISODATA analysis. In Proceedings of the 20th Annual Meeting of ISMRM, Melbourne, Australia, 2012. Abstract 1537.
11. Peng HH, Huang TY, Tseng WY, Lin EL, Chung HW, Wu CC, Wang YS, Chen WS. Simultaneous temperature and magnetization transfer (MT) monitoring during high-intensity focused ultrasound (HIFU) treatment: preliminary investigation on ex vivo porcine muscle. J Magn Reson Imaging 2009;30:596-605.
12. van Zijl PC, Yadav NN. Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med 2011;65: 927-948.
13. Liu G, Song X, Chan KW, McMahon MT. Nuts and bolts of chemical exchange saturation transfer MRI. NMR Biomed 2013;26:810-828.
14. Vinogradov E, Sherry AD, Lenkinski RE. CEST: from basic principles to applications, challenges and opportunities. J Magn Reson 2013; 229:155-172.
15. Jokivarsi KT, Grohn HI, Grohn OH, Kauppinen RA. Proton transfer ratio, lactate, and intracellular pH in acute cerebral ischemia. Magn Reson Med 2007;57:647-653.
16. Sun PZ, Sorensen AG. Imaging pH using the chemical exchange saturation transfer (CEST) MRI: correction of concomitant RF irradiation effects to quantify CEST MRI for chemical exchange rate and pH. Magn Reson Med 2008;60:390-397.
17. Zhou J, van Zijl PC. Defining an acidosis-based ischemic penumbra from pH-weighted MRI. Transl Stroke Res 2011;3:76-83.
18. Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 2003;50:1120-1126.
19. Salhotra A, Lal B, Laterra J, Sun PZ, van Zijl PC, Zhou J. Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed 2008;21:489-497.
20. Jones CK, Schlosser MJ, van Zijl PC, Pomper MG, Golay X, Zhou J. Amide proton transfer imaging of human brain tumors at 3T. Magn Reson Med 2006;56:585-592.
21. Zhou J. Amide proton transfer imaging of the human brain. Methods Mol Biol 2011;711:227-237.
22. Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, van Zijl PC. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med 2008;60:842-849.
23. Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003;49:223-232.
24. Dula AN, Arlinghaus LR, Dortch RD, Dewey BE, Whisenant JG, Ayers GD, Yankeelov TE, Smith SA. Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response. Magn Reson Med 2013;70:216-224.
25. Jia G, Abaza R, Williams JD, et al. Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging 2011; 33:647-654.
26. Zhou J, Tryggestad E, Wen Z, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 2011;17:130-134.
27. Seip R, Chin CT, Hall CS, Raju BI, Ghanem A, Tiemann K. Targeted ultrasound-mediated delivery of nanoparticles: on the development of a new HIFU-based therapy and imaging device. IEEE Trans Biomed Eng 2010;57:61-70.
28. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46:6387-6392.
29. Bellmann K, Charette SJ, Nadeau PJ, Poirier DJ, Loranger A, Landry J. The mechanism whereby heat shock induces apoptosis depends on the innate sensitivity of cells to stress. Cell Stress Chaperones 2010; 15:101-113.
30. Zhang Y, Calderwood SK. Autophagy, protein aggregation and hyperthermia: a mini-review. Int J Hyperthermia 2011;27:409-414.
31. Reinhold HS, Endrich B. Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia 1986;2:111-137.
32. Griffiths JR. Are cancer cells acidic? Br J Cancer 1991;64:425-427.
33. Delli Castelli D, Terreno E, Aime S. Yb(III)-HPDO3A: a dual pH-and temperature-responsive CEST agent. Angew Chem Int Ed Engl 2011; 50:1798-1800.
34. Longo DL, Dastru W, Digilio G, et al. Iopamidol as a responsive MRIchemical exchange saturation transfer contrast agent for pH mapping of kidneys: in vivo studies inmice at 7 T. Magn ResonMed 2011;65:202-211.
35. Kim M, Gillen J, Landman BA, Zhou J, van Zijl PC. Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med 2009;61:1441-1450.
36. Scheidegger R, Vinogradov E, Alsop DC. Amide proton transfer imaging with improved robustness to magnetic field inhomogeneity and magnetization transfer asymmetry using saturation with frequency alternating RF irradiation. Magn Reson Med 2011;66:1275-1285.
37. van Zijl PC, Zhou J, Mori N, Payen JF, Wilson D, Mori S. Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids. Magn Reson Med 2003;49:440-449.
38. Desmond KL, Moosvi F, Stanisz GJ. Mapping of amide, amine, and aliphatic peaks in the CEST spectra of murine xenografts at 7 T. Magn Reson Med 2014;71:1841-1853.
39. Zhao X, Wen Z, Huang F, Lu S, Wang X, Hu S, Zu D, Zhou J. Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T. Magn Reson Med 2011;66:1033-1041.
40. Jones CK, Polders D, Hua J, Zhu H, Hoogduin HJ, Zhou J, Luijten P, van Zijl PC. In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T. Magn Reson Med 2012;67:1579-1589.
41. Sun PZ, Murata Y, Lu J, Wang X, Lo EH, Sorensen AG. Relaxationcompensated fast multislice amide proton transfer (APT) imaging of acute ischemic stroke. Magn Reson Med 2008;59:1175-1182.
42. Zhao X, Wen Z, Zhang G, Huang F, Lu S, Wang X, Hu S, Chen M, Zhou J. Three-dimensional turbo-spin-echo amide proton transfer MR imaging at 3-Tesla and its application to high-grade human brain tumors. Mol Imaging Biol 2013;15:114-122.
43. Zhu H, Jones CK, van Zijl PC, Barker PB, Zhou J. Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med 2010;64:638-644.
44. Wijlemans JW, Deckers R, van den Bosch MA, Seinstra BA, van Stralen M, van Diest PJ, Moonen CT, Bartels LW. Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model. Invest Radiol 2013;48:381-386.
45. Aulino P, Berardi E, Cardillo VM, et al. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer 2010;10:363.
46. Ogawara K, Un K, Minato K, Tanaka K, Higaki K, Kimura T. Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors. Int J Pharm 2008; 359:234-240.
47. Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, Wang ZB. Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med Biol 2002;28: 535-542.